coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Rumworth PCN, Bolton (LAD) · Health Inequalities Profile

    PCN U07003 · NHS Greater Manchester Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    30,964

    Registered population

    60.3% aged 18–64

    14.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    61%

    Ethnic minority (non-White)

    47.4% Asian · England 9.6%

    70.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~20,376

    Core20 residents (est.)

    Resident basis; registered basis ~22,116 · see page 3

    4,215

    Hypertension register

    +1.67% in 3 yrs · England +5.60%

    345

    SMI register

    9.5% of Bolton (LAD)'s

    593

    COPD register

    Reviews +0.03% in 3 yrs

    Forecast to 2030

    4,462

    Hypertension patients, 2030

    +247 on today

    67.5%

    QRISK ≥20% on statins, 2030

    +2.02pp over 3 yrs

    2.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.0%
    Cervical screening at ages 25-49 trails England.

    Coverage is 52.0% (England 66.8 percent) after a -7.4% three-year change (England -1.0 percent), which could reflect unverified recall or access barriers.

    597
    Annual asthma reviews fell over three years.

    Asthma review coverage is 66.0% after a -3.0% three-year change (England +4.4 percent), leaving about 600 patients without a recorded review.

    90.2%
    Register care and control exceed national averages.

    SMI blood pressure checks reach 90.2% (England 83.4 percent), alongside 72.2% hypertension control to target and 88.7% annual heart failure reviews.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger list with 25.6% aged 0-17 sits alongside 47.4% Asian resident population

    Rumworth PCN serves 30,964 registered patients across four practices. The list is younger than benchmarks: 25.6% (7,934 patients) are aged 0-17 against 23.7% in Bolton (LAD), 21.8% in NHS Greater Manchester Integrated Care Board, and 19.6% in England, while 14.1% (4,361 patients) are aged 65+ (LAD 14.7%, ICB 14.9%, England 17.9%). In associated resident areas, Census estimates indicate a 61% ethnic minority population, led by Asian / Asian British residents at 47.4% (LAD 20.1%, ICB 13.6%, England 9.6%). These resident figures describe local catchments rather than verified patient registration coding.

    Age profile

    0–1725.6%
    18–6460.3%
    65+14.1%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    Asian47.4%
    White39.0%
    Black7.2%
    Other4.1%
    Mixed2.3%

    Older people · falls rows are Bolton (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Bolton LA)1,9232,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.7%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Bolton LA)9581,0219552024/25
    Falls deaths, all ages, per 100,000 (Bolton LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 70.6% across the PCN and varies widely between practices

    Rumworth PCN has an average IMD decile of 2.6, with 70.6% of registered patients in Core20 areas, above Bolton (47.8%), NHS Greater Manchester Integrated Care Board (40.7%) and England (21.0%). A weighted practice share of 71.4% differs from the PCN figure by 0.85 percentage points. Concentration spans 38.1 pp, from 43.9% at St Helens Road Practice to 82.0% at Swan Lane Medical Centre. By volume, Swan Lane Medical Centre has 7,848 estimated Core20 patients, followed by Pikes Lane 1 with 5,622. Outreach requires balancing concentration against practice volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Swan Lane82.0% · 7,848 patients
    Shanti80.8% · 5,113 patients
    Pikes Lane 180.1% · 5,622 patients
    St Helens Road43.9% · 3,533 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    345

    SMI register

    1.11% recorded prevalence

    176

    Learning disability register

    0.57% recorded prevalence

    17

    Care homes, 551 beds

    In the PCN catchment

    9.8%

    Provide unpaid care

    Bolton (LAD), Census 2021

    The PCN records 345 patients on its severe mental illness register (1.1% prevalence) and 176 on its learning disability register (0.6%), alongside 17 catchment care homes with 551 beds. Unpaid carers have a modelled ceiling estimate of 3,034 (about 3,000) using Bolton's 9.8% Census rate. Severe mental illness prevalence is 1.1% (England 1.0%), which could suggest prioritising physical health checks.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reach 90.2% (England 83.4%) and BMI recording is 87.8% (England 82.1%). Smoking cessation offers reach 93.9% (England 94.2%), including 91.3% at Pikes Lane 1 and 93.2% at St Helens Road Practice.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,215

    Hypertension register

    +1.67%

    Register growth, 3 yrs

    Bolton (LAD) +4.70% · England +5.60%

    +4.76pp

    BP control, under 80

    ≤140/90 · +5.41pp aged 80+

    +247

    More patients by 2030

    Forecast 4,462 (14.01%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 13.6% (4,215 patients), below Bolton (14.8%), NHS Greater Manchester ICB (14.4%) and England (15.2%), with three-year growth of +1.7% trailing England (+5.6%). Unadjusted register gap modelling indicates a shortfall of +354 to +501 patients, although this upper bound may be overstated by a younger age profile (14.1% aged 65+ vs England 17.9%). Practice prevalence ranges from 8.4% at Shanti Medical Centre to 16.6% at St Helens Road Practice. Meanwhile, 91.2% of patients have a recent blood pressure reading and 72.2% achieve target blood pressure control, exceeding England (70.3%). Lower recorded prevalence alongside strong control could indicate robust delivery while case finding could prioritise trailing practices.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid therapy uptake is 63.2%, trailing NHS Greater Manchester ICB (67.0%) and England (63.6%). For diabetic patients aged 40+ without cardiovascular disease, statin coverage fell 2.9% (England +2.1%) to 70.1% (ICB 75.7%). Fewer at-risk patients receive lipid-lowering therapy than regional comparators imply, prioritising primary prevention recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202655,155£1.50£1.94£1.86£82,732
    Cardiovascular (all), 202577,469£3.02£3.15£3.33£233,956

    In 2026, the PCN prescribed 55,155 items of lipid-regulating drugs at £1.50 per item, compared with £1.81 in Bolton, £1.94 in NHS Greater Manchester ICB, and £1.86 in England, spending £19,856 less than at England's unit cost. Lower unit cost indicates lower expenditure per item, but does not establish prescribing efficiency or treatment appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −3.02%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.68%

    Asthma prevalence, PCN 3-yr % change

    Rumworth PCN asthma prevalence is 6.1% (England 6.6%), covering 1,756 patients. Over three years, annual asthma reviews fell 3.0% (England +4.4%) to 66.0% (England 65.7%), spanning from 55.5% at Pikes Lane 1 to 70.9% at Swan Lane Medical Centre and leaving about 600 patients unreviewed. Youth asthma prescribing is 1,722 per 1,000 (England 1,488). COPD prevalence is 1.9% (593 patients; Bolton 2.4%), with reviews at 80.8% (England 76.4%). Lower review rates could reflect unverified recall barriers testable by audit.

    Cancer register and children's immunisation

    Cancer prevalence is 2.5% (763 patients), below England (3.8%) and Bolton (3.2%). For childhood immunisations, 6-in-1 coverage at 12 months is 88.1%, below the 95% target by 6.9 pp. At age 5, MMR dose 1 coverage is 93.3% and dose 2 is 85.4% (a 7.9 pp PCN difference), widening to 17.7 pp at Shanti Medical Centre (82.4% vs 64.7%), consistent with unverified recall barriers testable by audit.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.1%

    England 91.0%

    6-in-1 complete primary course at 24 months89.2%

    England 92.2%

    MMR dose 1 at 24 months90.3%

    England 88.3%

    MMR dose 2 at age 585.4%

    England 82.8%

    4-in-1 pre-school booster at age 583.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of staged cancers across NHS Greater Manchester ICB were diagnosed at stage 1 or 2 (6,491 of 11,679 with known stage), compared with 55.3% in England, with a distance of -19.4 pp to the 75.0% national ambition by 2028. Known-stage completeness was 70.8% across 16,492 registered cancers. Reaching 75.0% requires about 2,270 additional early-stage diagnoses annually across the ICB. While ICB staging reflects wider system pathways rather than PCN performance, Rumworth PCN cervical screening coverage at ages 25-49 is 52.0% (England 66.8%), after a -7.4% three-year change (England -1.0%). Lower screening coverage may delay early cancer detection, making practice recall audits a priority.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For July 2026, Bolton NHS Foundation Trust met the 62-day cancer referral to treatment standard for 69.7% of pathways, trailing the 85.0% standard by 15.3 pp and below Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust (76.8%), Northern Care Alliance NHS Foundation Trust (78.6%), NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). Conversely, Bolton achieved the 28-day faster diagnosis standard at 80.5% (standard 75.0%) and the 31-day combined treatment standard at 96.5% (standard 96.0%). Diagnostic 6+ week waits at Bolton were 19.4% for computed tomography and 25.3% for cystoscopy, whereas colonoscopy was 1.3%.

    Pathways within standard (%)BoltonWrightington, Wigan and LeighNorthern Care AllianceGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.4882.8075.2079.5379.32
    31-day treatment (96%)96.5089.0494.5496.4992.50
    62-day referral to treatment (85%)69.6676.7878.6575.7371.16
    Diagnostic waits over 6 weeks (%)BoltonWrightington, Wigan and LeighNorthern Care AllianceEngland
    MRI2.050.495.0921.40
    CT19.407.784.109.92
    Echocardiography3.4824.3731.4828.48
    Colonoscopy1.336.1040.0430.83
    Gastroscopy2.0612.5436.4829.02
    All 15 DM01 tests15.7814.3615.7123.14
    Community services activityBolton residentsGreater Manchester ICB
    Care contacts49,315573,310
    Referrals4,07594,470
    Patients with a contact17,765183,535

    Community services (residents of Bolton), Jun 2026 (provisional). In June 2026, adults aged 65 and over accounted for 51.6% of community service contacts among Bolton borough residents (25,460 of 49,315 contacts). These figures reflect borough-wide resident activity rather than Rumworth PCN registered patients, but demonstrate that community healthcare provision across the local authority is heavily focused on older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 35.1 pp across practices alongside uneven vaccination and immunisation achievement

    In 2025/26, clinical QOF achievement reached 98.7% at Swan Lane Medical Centre and 100.0% at Shanti Medical Centre, above England (97.1%). Conversely, vaccination and immunisation achievement fell below England (55.2%), spanning 16.3 pp from 16.6% at Pikes Lane 1 to 33.0% at Swan Lane Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    St Helens Road10743.985.3%78.8%87.3%
    Pikes Lane 19780.160.1%73.8%87.0%
    Swan Lane9882.059.7%83.2%81.0%
    Shanti9280.850.2%73.8%68.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBolton (LAD)AssetPCNBolton (LAD)
    Care homes (catchment)17 (551 beds)n/aSchools (catchment)49n/a
    Children's centres418Places of worship34144
    Librariesn/a7Primary schools (LA maintained)1261
    Primary academies532Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension case-finding and coding audit

    Recorded prevalence is 13.6% (4,215 of 30,964 patients) against Bolton (14.8%) and England (15.2%), a modelled gap of +354 to +501. For discussion: practices could search for patients with repeated raised blood pressure readings lacking a register code and offer opportunistic checks during routine contacts. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured annual asthma review recall

    Annual asthma reviews fell 3.0% from 2023 to 2025 (England +4.4%) to 66.0% of 1,756 patients, leaving 597 (about 600) unreviewed. For discussion: practices could run a standardized recall template, check inhaler prescribing alongside annual reviews, and trial after-school or flexible clinic slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Cervical screening and access outreach

    Cervical screening at ages 25-49 fell 7.4% (England -1.0%) to 52.0%, below Bolton (63.9%), the ICB (65.9%) and England (66.8%). For discussion: practices could audit non-responders, adapt reminder wording for the 47.4% Asian resident catchment, and review phone triage and flexible screening slots. Moderate effort to run.

    Evidence base: uptake is the delivery measure of the national cancer screening programme; distance to the acceptable and achievable standards is the outreach target.

    Policy anchor: Shift 3: sickness to prevention; Eliminate cervical cancer by 2040.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored primary care communication (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Second-dose MMR recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension case-finding and coding audit (p12)Hypertension register · Hypertension: QOF prevalence · Registered populationCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 3 · Cervical screening and access outreach (p12)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) · Asian / Asian British · GPPS easy to contact the practice by phoneFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15